文献速递冠心病心力衰竭与心肌病

COVID-19幸存者的MRI与CT冠状动脉造影研究

MRI and CT coronary angiography in survivors of COVID-19.
PubMed 文献 · Heart · 2021-10-06

这项前瞻性双中心观察性研究对52例COVID-19出院患者进行钆和锰增强MRI及CT冠状动脉造影,并与健康及合并症匹配志愿者比较。结果显示患者右室收缩功能减低,而左室心肌异常在合并症匹配后不再显著,提示既往报道的左室异常可能反映合并症。

要点

  • COVID-19康复者存在右室收缩功能减低,与合并症匹配志愿者相比仍显著。
  • 左室心肌native T1、ECV等异常在合并症匹配后无差异,提示既往左室异常报告可能受合并症影响。
  • CTCA显示约三分之一受检患者存在潜在冠心病,需关注合并症评估。

核心结论

  • COVID-19康复者表现为右室而非左室收缩功能不全,既往左室心肌异常报道可能反映既往存在的合并症。

研究设计与样本

  • 前瞻性双中心观察性研究,纳入52例确诊COVID-19住院后康复患者,中位年龄54岁,39例男性。
  • 患者接受钆和锰增强MRI及CT冠状动脉造影,并与健康志愿者(n=10)和合并症匹配志愿者(n=26)进行盲法比较。

主要发现

  • 与年轻健康志愿者相比,患者左室射血分数降低(57.4±11.1% vs 66.3±5%,p=0.02),右室射血分数降低(51.7±9.1% vs 60.5±4.9%,p≤0.0001),native T1升高(1225±46 vs 1197±30 ms,p=0.04),ECV升高(31±4% vs 24±3%,p<0.0003),锰摄取减低(6.9±0.9 vs 7.9±1.2 mL/100 g/min,p=0.01)。
  • 与合并症匹配志愿者相比,患者左室功能保留,但右室收缩功能减低(51.7±9.1% vs 59.3±4.9%,p=0.0005),native T1、ECV、晚期钆增强及锰摄取均无显著差异。
  • 上述发现与COVID-19疾病严重程度、心肌损伤存在与否或持续症状无关。

关键数值与推荐

  • 52例患者中29%(n=15)入住ICU,21%(n=11)接受机械通气。
  • 与合并症匹配志愿者相比,右室射血分数差异为51.7±9.1% vs 59.3±4.9%(p=0.0005),左室射血分数无显著差异。

临床怎么用

  • 对COVID-19康复者评估心脏受累时,应区分右室与左室功能异常,并充分考虑合并症的影响。
  • CTCA可辅助识别潜在冠心病,尤其对于有心血管危险因素的患者。
  • 左室心肌异常指标(如native T1、ECV)在合并症匹配后可能不具特异性,解读时需谨慎。

局限性

  • 样本量较小(52例患者),且为观察性研究,可能存在残余混杂。
  • 健康志愿者年龄较轻,与患者组年龄不匹配;合并症匹配志愿者样本量有限(n=26)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To determine the contribution of comorbidities on the reported widespread myocardial abnormalities in patients with recent COVID-19. METHODS: In a prospective two-centre observational study, patients hospitalised with confirmed COVID-19 underwent gadolinium and manganese-enhanced MRI and CT coronary angiography (CTCA). They were compared with healthy and comorbidity-matched volunteers after blinded analysis. RESULTS: In 52 patients (median age: 54 (IQR 51-57) years, 39 males) who recovered from COVID-19, one-third (n=15, 29%) were admitted to intensive care and a fifth (n=11, 21%) were ventilated. Twenty-three patients underwent CTCA, with one-third having underlying coronary artery disease (n=8, 35%). Compared with younger healthy volunteers (n=10), patients demonstrated reduced left (ejection fraction (EF): 57.4±11.1 (95% CI 54.0 to 60.1) versus 66.3±5 (95 CI 62.4 to 69.8)%; p=0.02) and right (EF: 51.7±9.1 (95% CI 53.9 to 60.1) vs 60.5±4.9 (95% CI 57.1 to 63.2)%; p≤0.0001) ventricular systolic function with elevated native T1 values (1225±46 (95% CI 1205 to 1240) vs 1197±30 (95% CI 1178 to 1216) ms;p=0.04) and extracellular volume fraction (ECV) (31±4 (95% CI 29.6 to 32.1) vs 24±3 (95% CI 22.4 to 26.4)%; p<0.0003) but reduced myocardial manganese uptake (6.9±0.9 (95% CI 6.5 to 7.3) vs 7.9±1.2 (95% CI 7.4 to 8.5) mL/100 g/min; p=0.01). Compared with comorbidity-matched volunteers (n=26), patients had preserved left ventricular function but reduced right ventricular systolic function (EF: 51.7±9.1 (95% CI 53.9 to 60.1) vs 59.3±4.9 (95% CI 51.0 to 66.5)%; p=0.0005) with comparable native T1 values (1225±46 (95% CI 1205 to 1240) vs 1227±51 (95% CI 1208 to 1246) ms; p=0.99), ECV (31±4 (95% CI 29.6 to 32.1) vs 29±5 (95% CI 27.0 to 31.2)%; p=0.35), presence of late gadolinium enhancement and manganese uptake. These findings remained irrespective of COVID-19 disease severity, presence of myocardial injury or ongoing symptoms. CONCLUSIONS: Patients demonstrate right but not left ventricular dysfunction. Previous reports of left ventricular myocardial abnormalities following COVID-19 may reflect pre-existing comorbidities. TRIAL REGISTRATION NUMBER: NCT04625075.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Singh T, Kite TA, Joshi SS, et al. MRI and CT coronary angiography in survivors of COVID-19. Heart. 2021. PMID: 34615668. doi:10.1136/heartjnl-2021-319926

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。